1332392-76-3 Usage
General Description
5-bromo-2-chloro-3-(difluoromethyl)pyridine is a chemical compound with the molecular formula C6H3BrClF2N. It is a pyridine derivative that contains bromine, chlorine, and difluoromethyl groups attached to the pyridine ring. 5-bromo-2-chloro-3-(difluoromethyl)pyridine is commonly used as an intermediate in organic synthesis to prepare various pharmaceuticals and agrochemicals. It is also used as a building block in the synthesis of novel organic molecules for research and development purposes. 5-bromo-2-chloro-3-(difluoromethyl)pyridine has potential applications in the field of medicinal chemistry and materials science, and its synthesis and properties are of interest to researchers in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1332392-76-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,2,3,9 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1332392-76:
(9*1)+(8*3)+(7*3)+(6*2)+(5*3)+(4*9)+(3*2)+(2*7)+(1*6)=143
143 % 10 = 3
So 1332392-76-3 is a valid CAS Registry Number.
1332392-76-3Relevant articles and documents
CYCLIC COMPOUNDS AND METHODS OF USING SAME
-
Page/Page column 241, (2021/07/02)
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.
SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS
-
Page/Page column 157, (2018/02/28)
Disclosed are compounds of the general formula (I), wherein R1-R3 are as defined herein, for use as MALT1 inhibitors in the treatment of autoimmune and inflammatory diseases or disorders. Methods of synthesizing the compounds are also disclosed. Also disc
